goralatide has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Q; He, L; Li, M; Li, W; Pang, Z; Wang, Z; Xu, C; Zhang, C; Zhang, W; Zhang, X; Zhang, Y; Zhou, J; Zhu, Y | 1 |
| Chen, YW; Ni, QW; Qu, CY; Xu, LM; Zhang, L; Zhang, Y; Zhou, M | 1 |
2 other study(ies) available for goralatide and Liver Cirrhosis
| Article | Year |
|---|---|
d-amino acid modification protects N-Acetyl-seryl-aspartyl-lysyl-proline from physiological hydroxylation and increases its antifibrotic effects on hepatic fibrosis.
Topics: Actins; Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Carbon Tetrachloride; Cell Proliferation; Chromatography, Liquid; Disease Models, Animal; Hepatic Stellate Cells; Humans; Hydroxylation; Liver; Liver Cirrhosis; Oligopeptides; Peptidyl-Dipeptidase A; Phosphorylation; Protective Agents; Rats; Smad2 Protein | 2019 |
Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
Topics: Actins; Animals; Bile Ducts; Bone Morphogenetic Protein 7; Collagen; Epithelial-Mesenchymal Transition; Fibroblasts; Gene Expression Regulation; Growth Inhibitors; Inflammation; Ligation; Liver; Liver Cirrhosis; Male; Muscle, Smooth; Oligopeptides; Osmosis; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2012 |